DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Staretz, M. E.
Right arrow Articles by Hecht, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Staretz, M. E.
Right arrow Articles by Hecht, S. S.

0090-9556/97/2502-0154-0162$02.00/0
DRUG METABOLISM AND DISPOSITION
Copyright © 1997 by The American Society for Pharmacology and Experimental Therapeutics
Vol. 25, No. 2

Comparative Metabolism of the Tobacco-Related Carcinogens Benzo[a]pyrene, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone, 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol, and N'-Nitrosonornicotine in Human Hepatic Microsomes

Marianne E. Staretz, Sharon E. Murphy, Christopher J. Patten, Maria G. Nunes, Werner Koehl, Shantu Amin, Leeann A. Koenig, F. Peter Guengerich, and Stephen S. Hecht

American Health Foundation (M.E.S., S.E.M., C.J.P., M.G.N., S.A., L.A.K., S.S.H.); Department of Food Chemistry and Environmental Toxicology (W.K.), University of Kaiserslautern; and Department of Biochemistry and Center in Molecular Toxicology (F.P.G.), Vanderbilt University School of Medicine

We compared the metabolism in human hepatic microsomes of three tobacco smoke carcinogens believed to be involved in the induction of cancer in humans: benzo[a]pyrene (BaP),4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), and N'-nitrosonornicotine (NNN). The metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), a major metabolite of NNK, was also investigated. Although the metabolism of some of these compounds by human enzymes or tissue preparations has been previously examined in some studies, they have never been compared in the same human hepatic samples. Moreover, there have been no previous reports of NNAL metabolism by human tissues or enzymes. The tritium-labeled carcinogens (3 µM) were incubated with 10 different human hepatic microsomal preparations and cofactors for 10-20 min, and the products were analyzed by radioflow HPLC. NNN was the best substrate for oxidative metabolism, with the 5'-hydroxylation pathway being the predominant one observed (mean ± SD = 31 ± 17 pmol/min/mg protein). alpha -Hydroxylation of NNK by the methylene and methyl hydroxylation metabolic activation pathways was the next fastest reaction, with rates of 3.1 ± 1.9 and 3.3 ± 1.1 pmol/min/mg protein, respectively. Metabolism of BaP resulted in the formation of dihydrodiols and phenols; trans-7,8-dihydro-7,8-dihydroxy-BaP, its major proximate carcinogen, was formed at a rate of 1.1 ± 0.61 pmol/min/mg protein. alpha -Hydroxylation of NNAL proceeded at a rate of 0.53 ± 0.26 pmol/min/mg protein. The results of this study demonstrate that human hepatic microsomes metabolize all of these tobacco carcinogens resulting in a substantial stream of electrophilic intermediates capable of binding to DNA. The relative rates of oxidative metabolism to electrophiles or their precursors were NNN > NNK > BaP > NNAL. Correlation studies indicated involvement of cytochrome P4502A6 in the 5'-hydroxylation of NNN and cytochrome P4503A4 in the alpha -methylene hydroxylation and pyridine-N-oxidation of NNK and NNAL. The results of this study provide the first data on the comparative metabolism of these important carcinogens in human hepatic microsomes.


Copyright © 1997 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
CarcinogenesisHome page
C. Azzi, J. Zhang, C. H. Purdon, J. M. Chapman, D. Nitcheva, J. R. Hebert, and E. W. Smith
Permeation and reservoir formation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and benzo[a]pyrene (B[a]P) across porcine esophageal tissue in the presence of ethanol and menthol
Carcinogenesis, January 1, 2006; 27(1): 137 - 145.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
S. H. Jee, H. Ohrr, J. W. Sull, and J. M. Samet
Cigarette Smoking, Alcohol Drinking, Hepatitis B, and Risk for Hepatocellular Carcinoma in Korea
J Natl Cancer Inst, December 15, 2004; 96(24): 1851 - 1856.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
P. Upadhyaya, C. L. Zimmerman, and S. S. Hecht
Metabolism and Pharmacokinetics of N'-Nitrosonornicotine in the Patas Monkey
Drug Metab. Dispos., October 1, 2002; 30(10): 1115 - 1122.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
B. Prokopczyk, N. Trushin, J. Leszczynska, S. E. Waggoner, and K. El-Bayoumy
Human cervical tissue metabolizes the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, via {{alpha}}-hydroxylation and carbonyl reduction pathways
Carcinogenesis, January 1, 2001; 22(1): 107 - 114.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. R.K. Sticha, M. E. Staretz, M. Wang, H. Liang, P. M.J. Kenney, and S. S. Hecht
Effects of benzyl isothiocyanate and phenethyl isothiocyanate on benzo[a]pyrene metabolism and DNA adduct formation in the A/J mouse
Carcinogenesis, September 1, 2000; 21(9): 1711 - 1719.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. F. Teiber and P. F. Hollenberg
Identification of the human liver microsomal cytochrome P450s involved in the metabolism of N-nitrosodi-n-propylamine
Carcinogenesis, August 1, 2000; 21(8): 1559 - 1566.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
P. Upadhyaya, S. G. Carmella, F.P. Guengerich, and S. S. Hecht
Formation and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol enantiomers in vitro in mouse, rat and human tissues
Carcinogenesis, June 1, 2000; 21(6): 1233 - 1238.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
S. S. Hecht
Tobacco Smoke Carcinogens and Lung Cancer
J Natl Cancer Inst, July 21, 1999; 91(14): 1194 - 1210.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1997 by the American Society for Pharmacology and Experimental Therapeutics.